ELANE and acute respiratory distress syndrome: Sivelestat, a selective neutrophil elastase inhibitor, has demonstrated therapeutic efficacy in acute respiratory distress syndrome (ARDS) by reducing alveolar damage [8] and suppressing neutrophil extracellular trap (NET) formation [9,10], processes intimately linked to endothelial dysfunction in sepsis [11].